David E. Goel

10% owner, Zentalis Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$10.0M

Companies

Latest trade

Dec 15, 2025

Companies

Zentalis Pharmaceuticals, Inc.10% owner −$10.0M

Trades

ZNTL Sold 7,500,000 shares at $1.33 $10.0M Dec 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.